{"id":{"repo_id":"soton","oai_identifier":"oai:eprints.soton.ac.uk:173793"},"canonical_url":"https://search.dev.ndltd.org/etd/soton/oai:eprints.soton.ac.uk:173793","repository":{"repo_id":"soton","name":"University of Southampton","base_url":"https://eprints.soton.ac.uk/cgi/oai2"},"display":{"title":"Early transition metal complexes of carbene donors linked to cyclopentadienyl ring analogues or amidine/amidinate moieties","abstract":"The new indenyl-functionalised NHC potassium salt, 1-[3-(4, 7-dimethylindenylpropyl]-3-<br/>(2,6-diisopropylphenyl)imidazol-2-ylidenepotassium, has been synthesised. Complexes of<br/>titanium, zirconium and chromium containing this ligand and the two carbon bridge analogue,<br/>1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-diisopropylphenyl)imidazol-2 ylidene potassium,<br/>have been synthesised and characterised by X-ray crystallographic techniques. The following<br/>complexes were tested as catalysts for the oligomerisation of ethylene in the presence of<br/>MAO: 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene(tertbutylimido)<br/>titanium chloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-<br/>dimethylindenyl)propyl]imidazol-2-ylidene(tert-butylimido)titanium chloride, 3-(2,6-<br/>diisopropylphenyl)-1-[3-(4,7-dimethylindenyl)propyl]imidazol-2-ylidenezirconium<br/>trichloride, 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]imidazol-2-<br/>ylidenezirconium trichloride, 3-(2,6-Diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-<br/>imidazol-2-ylidenechromium dichloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-<br/>(dimethylindenyl)propyl]imidazol-2-ylidene chromium dichloride, 3-(2,6-diisopropylphenyl)-<br/>1-[3-(4,7-dimethylindenyl)propyl]-imidazol-2-ylidene chromium methyl chloride and 3-(2,6-<br/>diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidenevanadium dichloride.<br/><br/>The following alkyl chromium complexes containing 1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-<br/>diisopropylphenyl)imidazol-2 ylidene potassium have also been synthesised: 3-(2,6-<br/>diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene chromium phenyl<br/>chloride and 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-dimethylindenyl)ethyl]-imidazol-2-ylidene<br/>chromium dibenzyl. Chromium cations have been synthesised using as starting materials the<br/>chromium alkyl complexes. The Cr(II) complex 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-<br/>dimethylindenyl)ethyl]-imidazol-2-ylidene chromium monochloride and a partially oxidised<br/>dimerised product were also isolated. 5-(2-chloroethyl)- 1, 2, 3, 4-tetramethylcyclopentadiene<br/>and 5-(3-chloropropyl) 1, 2, 3, 4-tetramethylcyclopentadiene were synthesised and isolated as<br/>geminal isomers for the first time.<br/><br/>The trialkyl chromium complex, tribenzyl chromium tris(tetrahydrofuran) was synthesised<br/>and also it was used as starting material for the complexes di(benzyl)chromium bis(1, 3-<br/>diisopropylimidazol-2-ylindene) and tri(benzyl)chromium TACN. All complexes were<br/>characterised by X-ray crystallography.<br/><br/>The imidazolium salt 3-(2.6-diisopropylphenyl)-1-[N, N-bis(2,6-<br/>diisopropylphenyl)acetamidyl] imidazolium chloride was synthesised and used as a precursor<br/>for the synthesis of amidinate-functionalised NHC zirconium and amidine-functionalised<br/>NHC silver complexes. Double deprotonation of 3-(2,6-diisopropylphenyl)-1-[N, N’-bis(2,6-<br/>diisopropylphenyl)acetamidyl] imidazolium chloride gave the amidinate-functionalised NHC<br/>ligand, 3-(2.6-diisopropylphenyl)-1-[2-N, N’bis(2,6<br/>diisopropylphenylamidinate)ethyl]imidazol-2-ylidenepotassium. Titanium, zirconium and<br/>chromium complexes containing this ligand were synthesised and characterised by X-ray<br/>crystallographic techniques. Transmetallation of the amidine-functionalised NHC silver<br/>complex with [Rh(COD)Cl]2 and [Ir(COD)Cl]2 gave the corresponding species. Rh(amidinefunctionalised<br/>NHC)(COD)Cl reacted with Na(BAr)4 (Ar = 3,5-CF3C6H3) to give the cation<br/>Rh(amidine-functionalised NHC)(COD)]+[BAr4]-. These species were also characterised by<br/>X-ray diffraction techniques.","abstract_html":"The new indenyl-functionalised NHC potassium salt, 1-[3-(4, 7-dimethylindenylpropyl]-3-&lt;br/&gt;(2,6-diisopropylphenyl)imidazol-2-ylidenepotassium, has been synthesised. Complexes of&lt;br/&gt;titanium, zirconium and chromium containing this ligand and the two carbon bridge analogue,&lt;br/&gt;1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-diisopropylphenyl)imidazol-2 ylidene potassium,&lt;br/&gt;have been synthesised and characterised by X-ray crystallographic techniques. The following&lt;br/&gt;complexes were tested as catalysts for the oligomerisation of ethylene in the presence of&lt;br/&gt;MAO: 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene(tertbutylimido)&lt;br/&gt;titanium chloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-&lt;br/&gt;dimethylindenyl)propyl]imidazol-2-ylidene(tert-butylimido)titanium chloride, 3-(2,6-&lt;br/&gt;diisopropylphenyl)-1-[3-(4,7-dimethylindenyl)propyl]imidazol-2-ylidenezirconium&lt;br/&gt;trichloride, 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]imidazol-2-&lt;br/&gt;ylidenezirconium trichloride, 3-(2,6-Diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-&lt;br/&gt;imidazol-2-ylidenechromium dichloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-&lt;br/&gt;(dimethylindenyl)propyl]imidazol-2-ylidene chromium dichloride, 3-(2,6-diisopropylphenyl)-&lt;br/&gt;1-[3-(4,7-dimethylindenyl)propyl]-imidazol-2-ylidene chromium methyl chloride and 3-(2,6-&lt;br/&gt;diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidenevanadium dichloride.&lt;br/&gt;&lt;br/&gt;The following alkyl chromium complexes containing 1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-&lt;br/&gt;diisopropylphenyl)imidazol-2 ylidene potassium have also been synthesised: 3-(2,6-&lt;br/&gt;diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene chromium phenyl&lt;br/&gt;chloride and 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-dimethylindenyl)ethyl]-imidazol-2-ylidene&lt;br/&gt;chromium dibenzyl. Chromium cations have been synthesised using as starting materials the&lt;br/&gt;chromium alkyl complexes. The Cr(II) complex 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-&lt;br/&gt;dimethylindenyl)ethyl]-imidazol-2-ylidene chromium monochloride and a partially oxidised&lt;br/&gt;dimerised product were also isolated. 5-(2-chloroethyl)- 1, 2, 3, 4-tetramethylcyclopentadiene&lt;br/&gt;and 5-(3-chloropropyl) 1, 2, 3, 4-tetramethylcyclopentadiene were synthesised and isolated as&lt;br/&gt;geminal isomers for the first time.&lt;br/&gt;&lt;br/&gt;The trialkyl chromium complex, tribenzyl chromium tris(tetrahydrofuran) was synthesised&lt;br/&gt;and also it was used as starting material for the complexes di(benzyl)chromium bis(1, 3-&lt;br/&gt;diisopropylimidazol-2-ylindene) and tri(benzyl)chromium TACN. All complexes were&lt;br/&gt;characterised by X-ray crystallography.&lt;br/&gt;&lt;br/&gt;The imidazolium salt 3-(2.6-diisopropylphenyl)-1-[N, N-bis(2,6-&lt;br/&gt;diisopropylphenyl)acetamidyl] imidazolium chloride was synthesised and used as a precursor&lt;br/&gt;for the synthesis of amidinate-functionalised NHC zirconium and amidine-functionalised&lt;br/&gt;NHC silver complexes. Double deprotonation of 3-(2,6-diisopropylphenyl)-1-[N, N’-bis(2,6-&lt;br/&gt;diisopropylphenyl)acetamidyl] imidazolium chloride gave the amidinate-functionalised NHC&lt;br/&gt;ligand, 3-(2.6-diisopropylphenyl)-1-[2-N, N’bis(2,6&lt;br/&gt;diisopropylphenylamidinate)ethyl]imidazol-2-ylidenepotassium. Titanium, zirconium and&lt;br/&gt;chromium complexes containing this ligand were synthesised and characterised by X-ray&lt;br/&gt;crystallographic techniques. Transmetallation of the amidine-functionalised NHC silver&lt;br/&gt;complex with [Rh(COD)Cl]2 and [Ir(COD)Cl]2 gave the corresponding species. Rh(amidinefunctionalised&lt;br/&gt;NHC)(COD)Cl reacted with Na(BAr)4 (Ar = 3,5-CF3C6H3) to give the cation&lt;br/&gt;Rh(amidine-functionalised NHC)(COD)]+[BAr4]-. These species were also characterised by&lt;br/&gt;X-ray diffraction techniques.","abstract_has_math":false,"creators":["Conde Guadano, Susana"],"institution":"University of Southampton","degree_name":"Ph.D.","degree_level":"doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Danopoulos, Andreas A."],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010-09","date_published":"2010-09","updated_at":"2026-07-24T04:36:21Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Danopoulos, Andreas A."]},{"key":"dc:creator","label":"Author","values":["Conde Guadano, Susana"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2010-09"]},{"key":"dc:date.issued","label":"Date","values":["2010-09"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Chemistry (pre 2011 reorg)","School of Chemistry"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Southampton"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://eprints.soton.ac.uk/173793/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["Ph.D."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://eprints.soton.ac.uk/173793/1/SCG_PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The new indenyl-functionalised NHC potassium salt, 1-[3-(4, 7-dimethylindenylpropyl]-3-<br/>(2,6-diisopropylphenyl)imidazol-2-ylidenepotassium, has been synthesised. Complexes of<br/>titanium, zirconium and chromium containing this ligand and the two carbon bridge analogue,<br/>1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-diisopropylphenyl)imidazol-2 ylidene potassium,<br/>have been synthesised and characterised by X-ray crystallographic techniques. The following<br/>complexes were tested as catalysts for the oligomerisation of ethylene in the presence of<br/>MAO: 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene(tertbutylimido)<br/>titanium chloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-<br/>dimethylindenyl)propyl]imidazol-2-ylidene(tert-butylimido)titanium chloride, 3-(2,6-<br/>diisopropylphenyl)-1-[3-(4,7-dimethylindenyl)propyl]imidazol-2-ylidenezirconium<br/>trichloride, 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]imidazol-2-<br/>ylidenezirconium trichloride, 3-(2,6-Diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-<br/>imidazol-2-ylidenechromium dichloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-<br/>(dimethylindenyl)propyl]imidazol-2-ylidene chromium dichloride, 3-(2,6-diisopropylphenyl)-<br/>1-[3-(4,7-dimethylindenyl)propyl]-imidazol-2-ylidene chromium methyl chloride and 3-(2,6-<br/>diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidenevanadium dichloride.<br/><br/>The following alkyl chromium complexes containing 1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-<br/>diisopropylphenyl)imidazol-2 ylidene potassium have also been synthesised: 3-(2,6-<br/>diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene chromium phenyl<br/>chloride and 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-dimethylindenyl)ethyl]-imidazol-2-ylidene<br/>chromium dibenzyl. Chromium cations have been synthesised using as starting materials the<br/>chromium alkyl complexes. The Cr(II) complex 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-<br/>dimethylindenyl)ethyl]-imidazol-2-ylidene chromium monochloride and a partially oxidised<br/>dimerised product were also isolated. 5-(2-chloroethyl)- 1, 2, 3, 4-tetramethylcyclopentadiene<br/>and 5-(3-chloropropyl) 1, 2, 3, 4-tetramethylcyclopentadiene were synthesised and isolated as<br/>geminal isomers for the first time.<br/><br/>The trialkyl chromium complex, tribenzyl chromium tris(tetrahydrofuran) was synthesised<br/>and also it was used as starting material for the complexes di(benzyl)chromium bis(1, 3-<br/>diisopropylimidazol-2-ylindene) and tri(benzyl)chromium TACN. All complexes were<br/>characterised by X-ray crystallography.<br/><br/>The imidazolium salt 3-(2.6-diisopropylphenyl)-1-[N, N-bis(2,6-<br/>diisopropylphenyl)acetamidyl] imidazolium chloride was synthesised and used as a precursor<br/>for the synthesis of amidinate-functionalised NHC zirconium and amidine-functionalised<br/>NHC silver complexes. Double deprotonation of 3-(2,6-diisopropylphenyl)-1-[N, N’-bis(2,6-<br/>diisopropylphenyl)acetamidyl] imidazolium chloride gave the amidinate-functionalised NHC<br/>ligand, 3-(2.6-diisopropylphenyl)-1-[2-N, N’bis(2,6<br/>diisopropylphenylamidinate)ethyl]imidazol-2-ylidenepotassium. Titanium, zirconium and<br/>chromium complexes containing this ligand were synthesised and characterised by X-ray<br/>crystallographic techniques. Transmetallation of the amidine-functionalised NHC silver<br/>complex with [Rh(COD)Cl]2 and [Ir(COD)Cl]2 gave the corresponding species. Rh(amidinefunctionalised<br/>NHC)(COD)Cl reacted with Na(BAr)4 (Ar = 3,5-CF3C6H3) to give the cation<br/>Rh(amidine-functionalised NHC)(COD)]+[BAr4]-. These species were also characterised by<br/>X-ray diffraction techniques."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dc:title","label":"Title","values":["Early transition metal complexes of carbene donors linked to cyclopentadienyl ring analogues or amidine/amidinate moieties"]}]}],"canonical_facts":{"dc:contributor.advisor":["Danopoulos, Andreas A."],"dc:creator":["Conde Guadano, Susana"],"dc:date":["2010-09"],"dc:date.issued":["2010-09"],"dc:description.abstract":["The new indenyl-functionalised NHC potassium salt, 1-[3-(4, 7-dimethylindenylpropyl]-3-<br/>(2,6-diisopropylphenyl)imidazol-2-ylidenepotassium, has been synthesised. Complexes of<br/>titanium, zirconium and chromium containing this ligand and the two carbon bridge analogue,<br/>1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-diisopropylphenyl)imidazol-2 ylidene potassium,<br/>have been synthesised and characterised by X-ray crystallographic techniques. The following<br/>complexes were tested as catalysts for the oligomerisation of ethylene in the presence of<br/>MAO: 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene(tertbutylimido)<br/>titanium chloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-<br/>dimethylindenyl)propyl]imidazol-2-ylidene(tert-butylimido)titanium chloride, 3-(2,6-<br/>diisopropylphenyl)-1-[3-(4,7-dimethylindenyl)propyl]imidazol-2-ylidenezirconium<br/>trichloride, 3-(2,6-diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]imidazol-2-<br/>ylidenezirconium trichloride, 3-(2,6-Diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-<br/>imidazol-2-ylidenechromium dichloride, 3-(2,6-diisopropylphenyl)-1-[3-(4,7-<br/>(dimethylindenyl)propyl]imidazol-2-ylidene chromium dichloride, 3-(2,6-diisopropylphenyl)-<br/>1-[3-(4,7-dimethylindenyl)propyl]-imidazol-2-ylidene chromium methyl chloride and 3-(2,6-<br/>diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidenevanadium dichloride.<br/><br/>The following alkyl chromium complexes containing 1-[2-(4,7-dimethylindenyl)ethyl]-3-(2,6-<br/>diisopropylphenyl)imidazol-2 ylidene potassium have also been synthesised: 3-(2,6-<br/>diisopropylphenyl)-1-[2-(4,7-dimethylindenyl)ethyl]-imidazol-2-ylidene chromium phenyl<br/>chloride and 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-dimethylindenyl)ethyl]-imidazol-2-ylidene<br/>chromium dibenzyl. Chromium cations have been synthesised using as starting materials the<br/>chromium alkyl complexes. The Cr(II) complex 3-(2,6-diisopropyl-phenyl)-1-[2-(4, 7-<br/>dimethylindenyl)ethyl]-imidazol-2-ylidene chromium monochloride and a partially oxidised<br/>dimerised product were also isolated. 5-(2-chloroethyl)- 1, 2, 3, 4-tetramethylcyclopentadiene<br/>and 5-(3-chloropropyl) 1, 2, 3, 4-tetramethylcyclopentadiene were synthesised and isolated as<br/>geminal isomers for the first time.<br/><br/>The trialkyl chromium complex, tribenzyl chromium tris(tetrahydrofuran) was synthesised<br/>and also it was used as starting material for the complexes di(benzyl)chromium bis(1, 3-<br/>diisopropylimidazol-2-ylindene) and tri(benzyl)chromium TACN. All complexes were<br/>characterised by X-ray crystallography.<br/><br/>The imidazolium salt 3-(2.6-diisopropylphenyl)-1-[N, N-bis(2,6-<br/>diisopropylphenyl)acetamidyl] imidazolium chloride was synthesised and used as a precursor<br/>for the synthesis of amidinate-functionalised NHC zirconium and amidine-functionalised<br/>NHC silver complexes. Double deprotonation of 3-(2,6-diisopropylphenyl)-1-[N, N’-bis(2,6-<br/>diisopropylphenyl)acetamidyl] imidazolium chloride gave the amidinate-functionalised NHC<br/>ligand, 3-(2.6-diisopropylphenyl)-1-[2-N, N’bis(2,6<br/>diisopropylphenylamidinate)ethyl]imidazol-2-ylidenepotassium. Titanium, zirconium and<br/>chromium complexes containing this ligand were synthesised and characterised by X-ray<br/>crystallographic techniques. Transmetallation of the amidine-functionalised NHC silver<br/>complex with [Rh(COD)Cl]2 and [Ir(COD)Cl]2 gave the corresponding species. Rh(amidinefunctionalised<br/>NHC)(COD)Cl reacted with Na(BAr)4 (Ar = 3,5-CF3C6H3) to give the cation<br/>Rh(amidine-functionalised NHC)(COD)]+[BAr4]-. These species were also characterised by<br/>X-ray diffraction techniques."],"dc:format":["text"],"dc:identifier.uri":["https://eprints.soton.ac.uk/173793/1/SCG_PhD.pdf"],"dc:publisher.department":["Chemistry (pre 2011 reorg)","School of Chemistry"],"dc:publisher.institution":["University of Southampton"],"dc:relation.isreferencedby":["https://eprints.soton.ac.uk/173793/"],"dc:title":["Early transition metal complexes of carbene donors linked to cyclopentadienyl ring analogues or amidine/amidinate moieties"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["Ph.D."]},"updated_at":"2026-07-24T04:36:21Z"}